Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
10/21/2024 | $430.00 | Neutral → Outperform | Wedbush |
7/9/2024 | $315.00 | Buy | Stifel |
6/6/2024 | $335.00 → $320.00 | Market Perform | Telsey Advisory Group |
3/28/2024 | $285.00 → $335.00 | Market Perform | Telsey Advisory Group |
12/8/2023 | $325.00 → $285.00 | Market Perform | Telsey Advisory Group |
12/5/2023 | $365.00 → $325.00 | Market Perform | Telsey Advisory Group |
6/29/2023 | $300.00 | Buy → Hold | Loop Capital |
3/6/2023 | $298.00 | Buy → Hold | Jefferies |
SC 13G - RH (0001528849) (Subject)
SC 13G - RH (0001528849) (Subject)
SC 13G/A - RH (0001528849) (Subject)
RH (NYSE:RH) has released its financial results for the second quarter ended August 3, 2024, in a shareholder letter from Chairman and Chief Executive Officer Gary Friedman, available on the Investor Relations section of its website at ir.rh.com. As previously announced, RH leadership will host a live conference call and audio webcast at 2:00 pm Pacific Time (5:00 pm Eastern Time) today. The live conference call may be accessed by dialing 800.225.9448 or 203.518.9708 for international callers (passcode: RHQ2). The call and replay can also be accessed via audio webcast at ir.rh.com. ABOUT RH RH (NYSE:RH) is a curator of design, taste and style in the luxury lifestyle market. The Company o
RH (NYSE:RH) today announced that it will report financial results for the second quarter ended August 3, 2024, on Thursday, September 12, 2024 after market close. RH's second quarter fiscal 2024 financial results press release will include a shareholder letter from Chairman and Chief Executive Officer, Gary Friedman, highlighting the Company's continued evolution and recent performance. The shareholder letter and financial results will be posted to the Company's investor relations website at ir.rh.com. RH leadership will host a live conference call and audio webcast at 2:00 pm Pacific Time (5:00 pm Eastern Time) on September 12, 2024. The live conference call may be accessed by dialing 8
RH (NYSE:RH) has released its financial results for the first quarter ended May 4, 2024, in a shareholder letter from Chairman and Chief Executive Officer Gary Friedman, available on the Investor Relations section of its website at ir.rh.com. As previously announced, RH leadership will host a live conference call and audio webcast at 2:00 pm Pacific Time (5:00 pm Eastern Time) today. The live conference call may be accessed by dialing 800.225.9448 or 203.518.9708 for international callers (passcode: RHQ1). The call and replay can also be accessed via audio webcast at ir.rh.com. ABOUT RH RH (NYSE:RH) is a curator of design, taste and style in the luxury lifestyle market. The Company of
RH (NYSE:RH) has released its financial results for the second quarter ended August 3, 2024, in a shareholder letter from Chairman and Chief Executive Officer Gary Friedman, available on the Investor Relations section of its website at ir.rh.com. As previously announced, RH leadership will host a live conference call and audio webcast at 2:00 pm Pacific Time (5:00 pm Eastern Time) today. The live conference call may be accessed by dialing 800.225.9448 or 203.518.9708 for international callers (passcode: RHQ2). The call and replay can also be accessed via audio webcast at ir.rh.com. ABOUT RH RH (NYSE:RH) is a curator of design, taste and style in the luxury lifestyle market. The Company o
RH (NYSE:RH) today announced that it will report financial results for the second quarter ended August 3, 2024, on Thursday, September 12, 2024 after market close. RH's second quarter fiscal 2024 financial results press release will include a shareholder letter from Chairman and Chief Executive Officer, Gary Friedman, highlighting the Company's continued evolution and recent performance. The shareholder letter and financial results will be posted to the Company's investor relations website at ir.rh.com. RH leadership will host a live conference call and audio webcast at 2:00 pm Pacific Time (5:00 pm Eastern Time) on September 12, 2024. The live conference call may be accessed by dialing 8
RH announced today that Chairman & CEO Gary Friedman completed the purchase of $10 million of RH stock at an average price per share of $216.10 representing 46,274 shares. With this purchase, Mr. Friedman beneficially owns as of June 26, 2024, 5,051,337 shares, or 25.1% of the outstanding shares of RH common stock, based on 18,445,222 shares outstanding as of June 7, 2024, as reported in RH's first quarter fiscal 2024 Form 10-Q. This represents an increase in Mr. Friedman's beneficial ownership by 0.2%. Mr. Friedman's beneficial ownership is determined for these purposes in accordance with the rules and regulations of the SEC and includes 1,700,000 shares of common stock issuable upon the
144 - RH (0001528849) (Subject)
144 - RH (0001528849) (Subject)
10-Q - RH (0001528849) (Filer)
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. Below are some instances of options activity happening in the Consumer Discretionary sector: Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume TSLA CALL TRADE NEUTRAL 07/19/24 $255.00 $60.5K 9.4K 56.5K XPEV CALL SWEEP
RH's (NYSE:RH) short percent of float has fallen 5.48% since its last report. The company recently reported that it has 2.05 million shares sold short, which is 26.21% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.7 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Short interest is important
RH (NYSE:RH) today announced the appointment of Jarrett Stuhl as Chief Real Estate & Development Officer. Mr. Stuhl will lead Real Estate Development, Architecture & Design for all the Company's brands, concepts and facilities, domestically and internationally. Mr. Stuhl will report to RH's Chairman and Chief Executive Officer, Gary Friedman. Prior to joining RH, Mr. Stuhl spent nine years bringing Soho House & Co. Inc into new markets across the world. Ascending through the company, and lastly serving as Chief Operating Officer for The Americas, Mr. Stuhl had responsibility for real estate, development, membership, communications, food & beverage and hotel operations. Gary Friedman,
SEATTLE, April 06, 2023 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ:RELY) ("Remitly"), a leading digital financial services provider for immigrants and their families, today announced the appointments of Phyllis Campbell and Ryno Blignaut to its Board of Directors. "We are delighted to welcome Phyllis and Ryno to Remitly's Board of Directors," said Matt Oppenheimer, CEO of Remitly. "They each bring with them a wealth of knowledge and leadership experience to complement our existing team of accomplished directors. I'm grateful for their passion and dedication to our customer-centric vision for the future of digital financial services." Campbell and Blignaut bring decades of leaders
Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/13/2021. Application Category: ANDA, Application Number: 213111, Application Classification:
Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE ; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/13/2021. Application Category: ANDA, Application Number: 213111, Application Classification:
Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE ; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/15/2021. Application Category: ANDA, Application Number: 213111, Application Classification:
4 - RH (0001528849) (Issuer)
4 - RH (0001528849) (Issuer)
4 - RH (0001528849) (Issuer)
Wedbush upgraded RH from Neutral to Outperform and set a new price target of $430.00
Stifel initiated coverage of RH with a rating of Buy and set a new price target of $315.00
Telsey Advisory Group reiterated coverage of RH with a rating of Market Perform and set a new price target of $320.00 from $335.00 previously